Purpose-built for physicians Q&A: Liraglutide outperforms colesevelam in reducing stool frequency in bile acid diarrhea Liraglutide reduced stool frequency in a small subset of patients with bile acid diarrhea and warrants consideration as a potential new treatment modality, according to research in The Lancet Gastroenterology and Hepatology
Market Report Coverage and Key Metrics Market Dynamics Drivers Shift to Oral Formulations The shift to oral formulations is a main driver of the GLP-1 market because it directly removes patient barriers, simplifies daily routines, needle anxiety, and eliminates complex cold chain logistics
The absence of tissue growth effects also means AOD-9604 avoids many common side effects of growth hormone therapy including joint pain and swelling from connective tissue proliferation, carpal tunnel syndrome from tissue expansion, edema and fluid retention from protein synthesis and sodium retention, and concerns about growth-promoting effects in individuals with tumor history
Figure 1 Table 1 Dynamic changes of laboratory indexes in AIDS patients with APL
( a ) Immunoblot for phosphorylated NF-kB subunit p65 in HepG2-HFL cells 4 hrs after stimulation with 5ppp or 5FAD as indicated
